The registration positions Healium Clinical for wider use in healthcare settings as a prescription-use immersive biofeedback, neurofeedback and relaxation training application. ...
Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security...
Selected from more than 680 applicants, the cohort will enter the eighth APAC Accelerator Program with access to mentorship, industry partners, investors and market access support. ...
The clearance expands Galvanize’s pulsed electric field portfolio for soft tissue ablation, supporting broader lesion treatment and limited US commercial release. ...
The submission moves PorTal Access closer to a planned mid-summer launch, positioning Flexi-Port as a differentiated vascular access solution for oncology and long-term infusion therapy. ...
Over 1,000 investment and business matching meetings, MoUs to support healthcare enterprises to go global ...
The company will present Proliv Rx, its FDA-approved physician-directed neuromodulation therapy for adults with major depressive disorder who have not responded adequately to antidepressant medication. ...
The FDA marketing authorisation establishes a new Class II device category for Aurie’s automated reusable no-touch intermittent urinary catheter system, with launch planned in Veterans Health Administration spinal cord injury hospitals later this year. ...
The FDA 510(k) clearance advances Biozen’s BP1000, a handheld fingertip device designed to deliver clinically validated spot blood pressure measurements without an arm cuff or per-user calibration. ...
The event highlighted healthcare AI’s shift from experimentation to real-world deployment, with discussions on accountability, governance, workforce readiness and exhibitor solutions including Heidi and AITRICS-VC....
